T1	Participants 127 183	patients with mixed dyslipidaemia and metabolic syndrome
T2	Participants 380 405	metabolic syndrome (MetS)
T3	Participants 585 627	patients with mixed dyslipidaemia and MetS
T4	Participants 662 744	patients with low-density lipoprotein cholesterol (LDL-C) > 160 and TG > 200â€ƒmg/dl
T5	Participants 793 799	n = 30
T6	Participants 875 882	n = 30)
T7	Participants 921 927	n = 30
